Thrombotic Thrombocytopenic Purpura

·MeSH: Purpura, Thrombotic Thrombocytopenic

9 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
anti-cd20 antibody	Sanofi (SNY)
recombinant adamts13	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-755	SHIRE PLC (SHPGF)
tak-755	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-755	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(1)

Drug	Company
tak-755	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 2/Phase 3(3)

Drug	Company
caplacizumab	Sanofi (SNY)
immunosuppressive treatment (eg	Sanofi (SNY)
plasma exchange	Sanofi (SNY)

BioSniper tracks 9 drugs in development for Thrombotic Thrombocytopenic Purpura across 4 companies.

There are 2 clinical trials targeting Thrombotic Thrombocytopenic Purpura tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.